Brief: Eton Pharmaceuticals Inc - Esteve To Pay Eur4 Million Up Front For Increlex Rights - SEC Filing
01/04/2025 12:31
April 1 (Reuters) - Eton Pharmaceuticals Inc ETON.O: ETON PHARMACEUTICALS INC - ESTEVE TO PAY EUR4 MILLION UP FRONT FOR INCRELEX RIGHTS - SEC FILING ETON PHARMACEUTICALS INC - ESTEVE HAS OPTION TO ACQUIRE INTERNATIONAL RIGHTS TO INCRELEX FOR EUR6 MILLION - SEC FILING Source text: [ID:n0001437749-25-010358] Further company coverage: ETON.O (((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer